Resistin could be a link between insulin resistance and obesity; its release reduces peripheral insulin sensitivity, increases endogenous glucose production by the liver, induces insulin resistance, and stimulates proinflammatory cytokines (e.g., IL-6 and tumor necrosis factor (TNF)-α) [52]. The gene discussed is INS; the disease is Insulin resistance.